JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB245592

Anti-ELL antibody

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Polyclonal ELL antibody. Suitable for IP and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ELL aa 150-200.

View Alternative Names

C19orf17, ELL, RNA polymerase II elongation factor ELL, Eleven-nineteen lysine-rich leukemia protein

1 Images
Immunoprecipitation - Anti-ELL antibody (AB245592)
  • IP

Supplier Data

Immunoprecipitation - Anti-ELL antibody (AB245592)

ELL was immunoprecipitated from HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate (1 mg per IP reaction; 20% of IP loaded).

ab245592 used for IP at 3 μg/mg lysate. For WB another anti-ELL antibody was used at 1 μg/ml.

Lane 1 : ab245592 IP in HeLa whole cell lysate.
Lane 2 : Control IgG in HeLa whole cell lysate.

Chemiluminescence detection : 30 seconds.

All lanes:

Immunoprecipitation - Anti-ELL antibody (ab245592)

Predicted band size: 68 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP

applications

Immunogen

Synthetic Peptide within Human ELL aa 150-200. The exact immunogen used to generate this antibody is proprietary information.

P55199

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-5 µg/mg of lysate", "IP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "" } } }
style
left-column
style
left-column
style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab245592 was affinity purified using an epitope specific to ELL immobilized on solid support.
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ELL also known as Eleven-nineteen lysine-rich leukemia is a transcription elongation factor. It has a molecular mass of approximately 69 kDa. This protein facilitates the process of transcriptional elongation by RNA polymerase II. ELL is widely expressed in various tissues with notable expression in the immune and hematopoietic systems. It interacts directly with RNA polymerase II and increases the transcriptional output by suppressing pausing of the polymerase on the DNA template.
Biological function summary

ELL enhances transcription processes which are fundamental to gene expression regulation. It can form complexes with other proteins such as the ELL-associated factor (EAF) proteins which aids in its function. These complexes modulate transcriptional elongation by coordinating with transcription initiation factors and co-activators. This role is important for maintaining proper cellular functions and regulating gene expression patterns necessary for cell differentiation and proliferation.

Pathways

ELL is involved in significant cellular signaling like the transcription regulators pathway. It functions alongside other transcription regulation factors such as the p-TEFb (positive transcription elongation factor b) complex. It contributes to control transcriptional elongation cycle and maintaining proper transcriptional dynamics within cells. Through its pathway interactions ELL works with Cyclin T1 from the p-TEFb complex influencing cell cycle and development processes.

ELL has implications in leukemia especially acute myeloid leukemia (AML). Chromosomal translocations that involve ELL result in fusion proteins that disrupt normal transcription processes leading to oncogenesis. ELL fusion proteins may interact with MLL (mixed-lineage leukemia) proteins in these conditions altering regulation of target genes and contributing to leukemia pathogenesis. ELL's malfunction also connects to pathological states involving transcriptional dysregulation impacting cellular growth and differentiation pathways linked with cancerous transformations.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed : 22195968, PubMed : 23932780). Specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription (PubMed : 23932780). ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.
See full target information ELL
style
left-column
style
left-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
style
left-column
style
right-column

Associated Products

Select an associated product type
Alternative Product
Primary Antibodies

AB264218

Anti-ELL antibody

primary-antibodies

ell-antibody-ab264218

0

(0 reviews)

style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com